Transcription of Association Bulletin #16-07 - AABB
{{id}} {{{paragraph}}}
Example: air traffic controller
Association Bulletin #16-07 - AABB
1 Association Bulletin #16-07 Date: September 28, 2016 To: AABB Members From: Donna M. Regan, MT(ASCP)SBB President Miriam A. Markowitz Chief Executive Officer Re: Updated Recommendations for Zika, Dengue, and Chikungunya Viruses Summary This Association Bulletin , developed by the AABB Transfusion Transmitted Diseases Committee and reviewed and approved by the AABB Board of Directors, is intended to supersede Association Bulletins #16-06 Blood Center and Public Health Actions to Reduce the Risk of Zika Virus Transfusion Transmission and #16-04 Zika, Dengue, and Chikungunya Viruses. The intent of this new Bulletin is to clarify and update information and AABB recommendations in light of the Food and Drug Administration (FDA) guidance documents Recommendations for Donor Screening, Deferral, and Product Management to Reduce the Risk of Transfusion-Transmission of Zika Virus, published February 16, 2016 (February guidance), and Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components, published August 26, 2016, (August guidance) classifying Zika virus as a relevant transfusion-transmitted infection (RTTI).
2 Provides information and recommendations on postdonation information (PDI) relevant to Zika, dengue, and chikungunya viruses Contains minimal information for human cells, …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: